U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 213

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr5:156191373
GRCh38:
Chr5:156764362
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
2.
GRCh37:
Chr5:156191336
GRCh38:
Chr5:156764325
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr5:156191187
GRCh38:
Chr5:156764176
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
4.
GRCh37:
Chr5:156191097
GRCh38:
Chr5:156764086
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr5:156189345
GRCh38:
Chr5:156762334
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr5:156189215
GRCh38:
Chr5:156762204
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr5:156189198
GRCh38:
Chr5:156762187
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr5:156189121
GRCh38:
Chr5:156762110
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr5:156187759
GRCh38:
Chr5:156760748
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr5:156187684
GRCh38:
Chr5:156760673
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr5:156187448
GRCh38:
Chr5:156760437
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr5:156187438
GRCh38:
Chr5:156760427
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr5:156187345
GRCh38:
Chr5:156760334
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr5:156184677
GRCh38:
Chr5:156757666
SGCDC220S, C221SQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr5:155935627
GRCh38:
Chr5:156508617
SGCDL69P, L70PQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr5:156193967
GRCh38:
Chr5:156766956
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr5:156192905
GRCh38:
Chr5:156765894
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr5:156192662
GRCh38:
Chr5:156765651
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr5:156192587
GRCh38:
Chr5:156765576
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr5:156192534
GRCh38:
Chr5:156765523
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr5:156192528
GRCh38:
Chr5:156765517
SGCDDilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr5:156188922
GRCh38:
Chr5:156761911
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr5:156188877
GRCh38:
Chr5:156761866
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr5:156187283
GRCh38:
Chr5:156760272
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr5:156187218
GRCh38:
Chr5:156760207
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Apr 20, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr5:156186962
GRCh38:
Chr5:156759951
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr5:156192465
GRCh38:
Chr5:156765454
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr5:156192285
GRCh38:
Chr5:156765274
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr5:156190852
GRCh38:
Chr5:156763841
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr5:156194757
GRCh38:
Chr5:156767746
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr5:156194752
GRCh38:
Chr5:156767741
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr5:156193423
GRCh38:
Chr5:156766412
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr5:156193386
GRCh38:
Chr5:156766375
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr5:156193276
GRCh38:
Chr5:156766265
SGCDQualitative or quantitative defects of delta-sarcoglycanBenign
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr5:156192220
GRCh38:
Chr5:156765209
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr5:156192140
GRCh38:
Chr5:156765129
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr5:156191816
GRCh38:
Chr5:156764805
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr5:156188567
GRCh38:
Chr5:156761556
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr5:156188553
GRCh38:
Chr5:156761542
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr5:156188540
GRCh38:
Chr5:156761529
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr5:156188490
GRCh38:
Chr5:156761479
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr5:156188405
GRCh38:
Chr5:156761394
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr5:156188391
GRCh38:
Chr5:156761380
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr5:156188308
GRCh38:
Chr5:156761297
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr5:156188307
GRCh38:
Chr5:156761296
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr5:156186936
GRCh38:
Chr5:156759925
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr5:156186841
GRCh38:
Chr5:156759830
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr5:156186574
GRCh38:
Chr5:156759563
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Mar 23, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr5:155753951
GRCh38:
Chr5:156326941
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr5:156193065
GRCh38:
Chr5:156766054
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr5:156193037
GRCh38:
Chr5:156766026
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr5:156192948
GRCh38:
Chr5:156765937
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr5:156192919
GRCh38:
Chr5:156765908
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr5:156191598
GRCh38:
Chr5:156764587
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr5:156189981
GRCh38:
Chr5:156762970
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr5:156188289
GRCh38:
Chr5:156761278
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr5:156188278
GRCh38:
Chr5:156761267
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr5:156188189
GRCh38:
Chr5:156761178
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr5:156187979
GRCh38:
Chr5:156760968
SGCDQualitative or quantitative defects of delta-sarcoglycanLikely benign
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr5:156184730
GRCh38:
Chr5:156757719
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr5:156194747
GRCh38:
Chr5:156767736
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr5:156194640
GRCh38:
Chr5:156767629
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr5:156194640
GRCh38:
Chr5:156767629
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr5:156194513
GRCh38:
Chr5:156767502
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
65.
GRCh37:
Chr5:156194472
GRCh38:
Chr5:156767461
SGCDQualitative or quantitative defects of delta-sarcoglycanBenign
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr5:156194442
GRCh38:
Chr5:156767431
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr5:156194278
GRCh38:
Chr5:156767267
SGCDQualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr5:155756603
GRCh38:
Chr5:156329593
SGCDAutosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, not specified
Conflicting interpretations of pathogenicity
(Oct 9, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr5:156186360
GRCh38:
Chr5:156759349
SGCDA278T, A277TQualitative or quantitative defects of delta-sarcoglycan, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr5:156186245
GRCh38:
Chr5:156759234
SGCDnot specified, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Inborn genetic diseases, not provided
Conflicting interpretations of pathogenicity
(Oct 9, 2022)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr5:156194781
GRCh38:
Chr5:156767770
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr5:156194756
GRCh38:
Chr5:156767745
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr5:156194511
GRCh38:
Chr5:156767500
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr5:156194495-156194496
GRCh38:
Chr5:156767484-156767485
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
75.
GRCh37:
Chr5:156194495-156194496
GRCh38:
Chr5:156767484-156767485
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
76.
GRCh37:
Chr5:156194272
GRCh38:
Chr5:156767261
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr5:156194267
GRCh38:
Chr5:156767256
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanBenign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr5:156194217
GRCh38:
Chr5:156767206
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveBenign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr5:156194216
GRCh38:
Chr5:156767205
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr5:156194215
GRCh38:
Chr5:156767204
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanBenign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr5:156193997
GRCh38:
Chr5:156766986
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Limb-Girdle Muscular Dystrophy, Recessive
Benign/Likely benign
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr5:156193960
GRCh38:
Chr5:156766949
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr5:156193922
GRCh38:
Chr5:156766911
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanConflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr5:156193908
GRCh38:
Chr5:156766897
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr5:156193907
GRCh38:
Chr5:156766896
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr5:156193890
GRCh38:
Chr5:156766879
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr5:156193701
GRCh38:
Chr5:156766690
SGCDQualitative or quantitative defects of delta-sarcoglycan, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
Benign/Likely benign
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr5:156193699
GRCh38:
Chr5:156766688
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr5:156193632
GRCh38:
Chr5:156766621
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr5:156193620
GRCh38:
Chr5:156766609
SGCDLimb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycanUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr5:156193597
GRCh38:
Chr5:156766586
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr5:156193318
GRCh38:
Chr5:156766307
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveConflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr5:156193234
GRCh38:
Chr5:156766223
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F,
Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr5:156193186
GRCh38:
Chr5:156766175
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr5:156193118
GRCh38:
Chr5:156766107
SGCDnot provided, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L,
Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
Benign
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr5:156193084
GRCh38:
Chr5:156766073
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveLikely benign
(Jan 12, 2018)
criteria provided, single submitter
97.
GRCh37:
Chr5:156193066
GRCh38:
Chr5:156766055
SGCDQualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, RecessiveBenign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
98.
GRCh37:
Chr5:156193062
GRCh38:
Chr5:156766051
SGCDQualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
99.
GRCh37:
Chr5:156193046
GRCh38:
Chr5:156766035
SGCDQualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant, Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
100.
GRCh37:
Chr5:156193045-156193046
GRCh38:
Chr5:156766034-156766035
SGCDDilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan,
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated Cardiomyopathy, Dominant, Dilated cardiomyopathy 1L,
Limb-Girdle Muscular Dystrophy, Recessive
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination